T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
TotalEnergies
TTE
$195B
| $950M | 0.2% |
11,838,112,289,406
+3,776,048,947,093
| +47% | +$378M |
|
127
International Paper
IP
$22.1B
| $947M | 0.2% |
23,595,944
-4,029,789
| -15% | -$160M |
|
128
HCA Healthcare
HCA
$89.1B
| $939M | 0.2% |
12,189,155
-1,179,921
| -9% | -$93.1M |
|
|
XL
129
DELISTED
XL Group Ltd.
XL
| $936M | 0.2% |
28,111,929
+76,789
| +0.3% | +$2.62M |
|
130
CVS Health
CVS
$120B
| $929M | 0.2% |
9,700,473
-7,147,975
| -42% | -$712M |
|
131
Fidelity National Financial
FNF
$12.8B
| $909M | 0.19% |
34,897,444
+1,254,177
| +4% | +$29.5M |
|
132
Qualcomm
QCOM
$171B
| $898M | 0.19% |
16,768,420
-232,734
| -1% | -$12.3M |
|
133
Northern Trust
NTRS
$34.4B
| $894M | 0.19% |
13,492,832
-100,507
| -0.7% | -$7M |
|
|
N
134
DELISTED
Netsuite Inc
N
| $888M | 0.19% |
12,195,296
-7,149
| -0.1% | -$548K |
|
135
Illinois Tool Works
ITW
$83.5B
| $886M | 0.19% |
8,503,942
+992,010
| +13% | +$104M |
|
136
Microchip Technology
MCHP
$44B
| $882M | 0.19% |
34,762,172
+870,576
| +3% | +$21.7M |
|
137
Bank of America
BAC
$448B
| $880M | 0.19% |
66,352,164
-7,920,925
| -11% | -$111M |
|
138
Ball Corp
BALL
$16.6B
| $854M | 0.18% |
23,621,580
+7,060,572
| +43% | +$256M |
|
139
Teleflex
TFX
$5.91B
| $854M | 0.18% |
4,813,605
+15,396
| +0.3% | +$2.51M |
|
140
Franco-Nevada
FNV
$46.4B
| $838M | 0.18% |
11,053,767
-443,839
| -4% | -$30M |
|
141
Equifax
EFX
$21.4B
| $834M | 0.18% |
6,498,844
-112,069
| -2% | -$13.6M |
|
142
CarMax
KMX
$8.26B
| $832M | 0.18% |
16,968,578
-8,196,784
| -33% | -$421M |
|
|
KSU
143
DELISTED
Kansas City Southern
KSU
| $832M | 0.18% |
9,233,517
-167,473
| -2% | -$15.2M |
|
144
Applied Materials
AMAT
$417B
| $832M | 0.18% |
34,700,319
-26,422,096
| -43% | -$583M |
|
145
Dentsply Sirona
XRAY
$2.31B
| $824M | 0.17% |
13,275,389
+379,836
| +3% | +$23.4M |
|
146
Centene
CNC
$32.1B
| $823M | 0.17% |
23,071,740
+7,516,428
| +48% | +$236M |
|
147
Canadian Pacific Kansas City
CP
$80.8B
| $813M | 0.17% |
31,594,205
-28,804,075
| -48% | -$777M |
|
148
Alkermes
ALKS
$8.26B
| $808M | 0.17% |
18,701,252
-614,674
| -3% | -$25.4M |
|
149
Martin Marietta Materials
MLM
$33.3B
| $799M | 0.17% |
4,163,543
-975,725
| -19% | -$175M |
|
150
Sensata Technologies
ST
$6.73B
| $799M | 0.17% |
22,897,514
+4,732,215
| +26% | +$173M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.